Metabolomics—the nontargeted measurement of all metabolites produced by the body—holds promise for early diagnosis, increased choice of therapy and the identification of new metabolic pathways that could potentially be targeted in kidney disease. This Review discusses the techniques used in metabolomics and explores the limitations and future applications of this process.
- Robert H. Weiss
- Kyoungmi Kim